Astera Labs

ALAB · NASDAQ · USD

$350.33Change from previous close: −1.71%Absolute change: −$6.09

Close · October 2, 2026

At a glance

Revenue growth
+115.13%
2025 vs 2024
Net margin
25.7%
2024: -21.1%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue39230827123119215914111376.965.350.536.9
Cost of revenue10573.266.154.846.440.036.625.217.014.711.58.8
Gross profit28823520417614611910487.959.950.539.028.1
Selling, general and administrative62.447.743.741.539.143.647.846.144.179.910.49.5
Research and development13612693.878.966.764.656.550.740.153.619.720.6
Operating income89.261.867.055.439.811.30.1-8.9-24.3-83.09.0-2.0
EBIT89.261.867.055.439.811.30.1-8.9-24.3-83.09.0-2.0
EBITDA93.265.569.856.941.212.41.1-8.0-23.6-82.49.6-1.5
Pre-tax income10373.478.966.950.721.710.72.0-14.1-80.410.7-0.3
Income tax-50.3-6.933.9-24.3-0.6-10.1-14.09.6-6.512.6-3.62.9
Net income15380.345.091.151.231.824.7-7.6-7.5-93.014.3-3.1
Net income to common shareholders15380.345.091.151.231.824.7-7.6-7.5-93.014.3-3.1
Basic EPS0.890.470.270.540.310.190.15-0.05-0.05-1.770.37-0.08
Diluted EPS0.830.440.250.500.290.180.14-0.05-0.05-1.770.37-0.08
Average shares (basic)17217117016716516316015715552.538.637.5
Average shares (diluted)18318118118117817817815715552.538.637.5